Literature DB >> 22265640

Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.

Stephanie G Park1, Katiah Llerena, Julie M McCarthy, Shannon M Couture, Melanie E Bennett, Jack J Blanchard.   

Abstract

Though negative symptoms in schizophrenia are associated with a host of deleterious outcomes (e.g., White et al., 2009), not all individuals with schizophrenia suffer from negative symptoms (e.g., Blanchard et al., 2005). Thus, methods to quickly screen and identify patients for more intensive clinical interview assessments may have significant clinical and research utility. The present study is a preliminary examination of the reliability and validity of a self-report version of the newly developed Clinical Assessment Interview for Negative Symptoms (CAINS; Blanchard et al., 2011; Forbes et al., 2010; Horan et al., 2011). The CAINS-SR is a 30-item self-report measure that assesses Experiential (avolition, anhedonia, asociality) and Expressive (blunted affect, alogia) domains of negative symptoms. Participants (N = 69) completed the CAINS-SR questionnaire and were evaluated with symptom interviews using the CAINS and other non-negative symptom interviews that assessed psychotic, affective, and other symptoms. The Experience subscale of the CAINS-SR demonstrated good internal consistency, convergent validity, and discriminant validity, while the poorer psychometric properties of the Expression subscale suggest that self-report of negative symptoms should focus on the experiential domain. Overall, preliminary findings indicate that the CAINS-SR (addressing experiential deficits) may be a useful complement to the clinician-rated interview measure. Future research on the sensitivity and specificity of the CAINS-SR will determine its suitability as a screening measure.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22265640      PMCID: PMC7201303          DOI: 10.1016/j.schres.2011.12.007

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  28 in total

1.  Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.

Authors:  J P Selten; D Wiersma; R J van den Bosch
Journal:  Compr Psychiatry       Date:  2000 May-Jun       Impact factor: 3.735

2.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Authors:  J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-08

3.  Treatment of schizophrenia negative symptoms: future prospects.

Authors:  Stephen M Erhart; Stephen R Marder; William T Carpenter
Journal:  Schizophr Bull       Date:  2006-02-21       Impact factor: 9.306

4.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

5.  The Positive and Negative Symptoms Questionnaire: a self-report scale in schizophrenia.

Authors:  Iulian Iancu; Amir Poreh; Benny Lehman; Eyal Shamir; Moshe Kotler
Journal:  Compr Psychiatry       Date:  2005 Jan-Feb       Impact factor: 3.735

6.  Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).

Authors:  Courtney Forbes; Jack J Blanchard; Melanie Bennett; William P Horan; Ann Kring; Raquel Gur
Journal:  Schizophr Res       Date:  2010-09-24       Impact factor: 4.939

7.  Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.

Authors:  Jack J Blanchard; Ann M Kring; William P Horan; Raquel Gur
Journal:  Schizophr Bull       Date:  2010-09-22       Impact factor: 9.306

8.  The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

Authors:  B Kirkpatrick; R W Buchanan; P D McKenney; L D Alphs; W T Carpenter
Journal:  Psychiatry Res       Date:  1989-11       Impact factor: 3.222

9.  [Negative symptoms of schizophrenic patients from the perspective of psychiatrists, patients themselves and their relatives].

Authors:  R Bottlender; M Jäger; I Kunze; C Groll; I Borski; H-J Möller
Journal:  Nervenarzt       Date:  2003-09       Impact factor: 1.214

10.  Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview.

Authors:  Ian Kelleher; Michelle Harley; Aileen Murtagh; Mary Cannon
Journal:  Schizophr Bull       Date:  2009-06-19       Impact factor: 9.306

View more
  10 in total

1.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

Review 2.  Psychometric evaluation of the negative syndrome of schizophrenia.

Authors:  Maria Paz Garcia-Portilla; Leticia Garcia-Alvarez; Pilar A Saiz; Susana Al-Halabi; Maria Teresa Bobes-Bascaran; Maria Teresa Bascaran; José Muñiz; Julio Bobes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

Review 3.  Anhedonia: a concept analysis.

Authors:  Nancy Ho; Marilyn Sommers
Journal:  Arch Psychiatr Nurs       Date:  2013-04-24       Impact factor: 2.218

4.  The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.

Authors:  Katiah Llerena; Stephanie G Park; Julie M McCarthy; Shannon M Couture; Melanie E Bennett; Jack J Blanchard
Journal:  Compr Psychiatry       Date:  2013-01-22       Impact factor: 3.735

5.  The Relationship of Motivation and Neurocognition with Functionality in Schizophrenia: A Meta-analytic Review.

Authors:  Antonia Najas-Garcia; Juana Gómez-Benito; Tania B Huedo-Medina
Journal:  Community Ment Health J       Date:  2018-03-31

6.  Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis.

Authors:  Matthew E Hudgens-Haney; Brett A Clementz; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Sarah K Keedy; John A Sweeney; Florence Gaudoux; Pierre Bunouf; Benoit Canolle; Françoise Tonner; Silvia Gatti-McArthur; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2020-02-11       Impact factor: 9.306

7.  Factor Structure, Convergent, and Divergent Validity of the Prodromal Questionnaire-Negative Symptom Subscale.

Authors:  Katherine M Pierce; Seth D Maxwell; Thomas M Olino; Shanna Cooper; Lauren M Ellman
Journal:  Assessment       Date:  2020-01-19

8.  Instruments measuring blunted affect in schizophrenia: a systematic review.

Authors:  Sanja Kilian; Laila Asmal; Anneke Goosen; Bonginkosi Chiliza; Lebogang Phahladira; Robin Emsley
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

9.  Measuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-Report.

Authors:  Ji-Sun Kim; Seon-Kyeong Jang; Seon-Cheol Park; Jung-Seo Yi; Joong-Kyu Park; Jung Suk Lee; Kee-Hong Choi; Seung-Hwan Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-11       Impact factor: 2.570

10.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.